Cyclerion Therapeutics, Inc. and Kiora Pharmaceuticals are newly listed on the NASDAQ stock exchange.
1 report, 1 independent
Updated Sep 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cyclerion Therapeutics, Inc. and Kiora Pharmaceuticals are newly listed on the NASDAQ stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Candel Therapeutics stock was listed on the Nasdaq exchange on August 18, 2026.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- Tempest Therapeutics, Inc. listed its shares on the Nasdaq electronic stock exchange on July 1, 2026.
- Decoy Therapeutics was listed on the Nasdaq stock exchange on September 22, 2026.
- Alvotech utilized Nasdaq for its public stock listing and is currently undergoing comprehensive review by the FDA for biosimilar applications.